ArticleMaterials (Basel, Switzerland)2023
Compact Wearable Antenna with Metasurface for Millimeter-Wave Radar Applications.
Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Three metasurfaces (MTS) are designed to be combined with a series end-fed 1 × 10 array antenna with a modified Dolph-Chebyshev distribution for imaging applications in the millimeter frequency range, 24.05-24.25 GHz. A reduction in secondary lobes and an increase in FTBR can be achieved while preserving gain, radiation efficiency, SLL and size using an MTS-array combination. Moreover, as a result of each single-layer MTS-array combination, operation bandwidth is widened, with gain and radiation efficiency enhancement. The overall devices' size is 86.8 × 12 × 0.762 mm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.